Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. (Q45972244)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. |
scientific article |
Statements
1 reference
Msx2 gene dosage influences the number of proliferative osteogenic cells in growth centers of the developing murine skull: a possible mechanism for MSX2-mediated craniosynostosis in humans. (English)
1 reference
Liu YH
1 reference
Tang Z
1 reference
Kundu RK
1 reference
Wu L
1 reference
Luo W
1 reference
Zhu D
1 reference
Sangiorgi F
1 reference
Snead ML
1 reference
Maxson RE
1 reference
1 January 1999
1 reference
1 reference
205
1 reference
2
1 reference
260-274
1 reference
Identifiers
1 reference
1 reference